10x Genomics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TXG research report →
Companywww.10xgenomics.com
10x Genomics, Inc. , a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products.
- CEO
- Serge Saxonov
- IPO
- 2019
- Employees
- 1,306
- HQ
- Pleasanton, CA, US
Price Chart
Valuation
- Market Cap
- $3.04B
- P/E
- -135.79
- P/S
- 4.77
- P/B
- 3.78
- EV/EBITDA
- -447.68
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 69.60%
- Op Margin
- -6.06%
- Net Margin
- -3.55%
- ROE
- -2.86%
- ROIC
- -4.24%
Growth & Income
- Revenue
- $642.82M · 5.25%
- Net Income
- $-43,544,000 · 76.16%
- EPS
- $-0.35 · 76.97%
- Op Income
- $-110,885,000
- FCF YoY
- 2371.16%
Performance & Tape
- 52W High
- $26.45
- 52W Low
- $8.06
- 50D MA
- $21.45
- 200D MA
- $17.44
- Beta
- 2.05
- Avg Volume
- 2.50M
Get TickerSpark's AI analysis on TXG
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 14, 26 | Saxonov Serge | sell | 5,000 |
| Mar 23, 26 | Saxonov Serge | sell | 10,000 |
| Mar 24, 26 | Saxonov Serge | sell | 5,000 |
| Mar 2, 26 | Saxonov Serge | sell | 14,292 |
| Mar 2, 26 | Saxonov Serge | sell | 1,860 |
| Mar 3, 26 | Saxonov Serge | other | 2,750 |
| Feb 26, 26 | Saxonov Serge | other | 157,895 |
| Feb 26, 26 | Hindson Benjamin J. | other | 88,816 |
| Feb 26, 26 | Taich Adam | other | 106,579 |
| Feb 25, 26 | Teichmann Sarah A. | sell | 7,579 |
Our TXG Coverage
We haven't published any research on TXG yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TXG Report →